XORI CORPORATION

XORI Corporation develops technology for discovery and development of monoclonal antibodies which are used to treat cancers, immune disorders and infectious diseases using DNA from Escherichia coli (E. coli) bacteria. The company was founded in 2009 and is based in Seattle, Washington.